Menu
Enrolling by invitation NCT06958003

Neonatal Intensive Care Unit (NICU) Diaper Dermatitis: Prevention and Treatment With Airtime

No phase Interventional Diaper Dermatitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Air Therapy.
Who it may be relevant to
Registry conditions: Diaper Dermatitis. Basic parameters: 30 Weeks — 1 year · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The purpose of this study is to investigate the use of 3-5 minutes air therapy for the prevention and treatment of diaper dermatitis in infants 30 weeks and older receiving care in the neonatal intensive care unit (NICU).

Interventions

  • Other Air Therapy
    3-5 minutes of air therapy in addition to routine diaper care

Primary outcome measures

  • Occurrence of diaper dermatitis [Time frame: from admission to discharge from NICU, up to 6 months]

Eligibility criteria

Inclusion criteria

  • Receiving care at Good Samaritan Hospital NICU
  • At least 30 weeks gestation at birth and corrected or older or corrected gestation
  • Birth to 1 year old
  • Stable vital signs (temperature, pulse, blood pressure, and oxygen saturation)

Exclusion criteria

  • Parent/legal guardian unable or unavailable to consent to involvement in the study
  • Congenital malformation impacting diaper area or spine

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 1 center
  • Good Samaritan Hospital — Cincinnati

Identifiers

NCT: NCT06958003 · 24-091

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗